The Urology Devices Market is predicted to reach US$ by 2030 from US$ 36.5 billion in 2021, and to grow at a CAGR of 3.9% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Product Type (Endoscopy Devices, Benign Prostatic Hyperplasia Treatment Devices, Dialysis Equipment, Urinary Stone Treatment Devices, Urinary Incontinence & Pelvic Organ Prolapse), By Technology (Robotic Surgery and Minimally Invasive Surgery), By Applications (Ureteroscopy, Lithotripsy, Orchiopexy, Vasectomy, Cystoscopy, Prostate Procedures, and Others) and By End Users (Research Centers and Hospitals
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Baxter International Inc, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc., Coloplast A/S, Cook Medical, Fresenius Medical Care AG & Co. KGaA, HealthTronics Inc., Intuitive Surgical Inc, Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic, Siemens Healthineers AG, Olympus Corporation, Richard Wolf GmbH, and Stryker Corporation.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Urology Devices - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Urology Devices - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Urology Devices - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Urology Devices - ANALYSIS & FORECAST, BY REGION
North America Urology Devices
1. North America Urology Devices , by Country
1. US
2. Canada
1. North America Urology Devices , by Product
2. North America Urology Devices , by Type
3. North America Urology Devices , by Gender
4. North America Urology Devices , by Sales Channel
3. Europe Urology Devices
1. Europe Urology Devices , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Urology Devices , by Product
3. Europe Urology Devices , by Type
4. Europe Urology Devices , by Gender
5. Europe Urology Devices , by Sales Channel
4. Asia Pacific Urology Devices
1. Asia Pacific Urology Devices , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Urology Devices , by product
3. Asia Pacific Urology Devices , by Type
4. Asia Pacific Urology Devices , by Gender
5. Asia Pacific Urology Devices , by Sales Channel
5. Rest of the World Urology Devices
1. Rest of the World Urology Devices , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Urology Devices , by Product
3. Rest of the World Urology Devices , by Type
4. Rest of the World Urology Devices , by Gender
5. Rest of the World Urology Devices , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 5